Research News & Funding Opportunities for Tulane Cancer Researchers - May 28, 2024 | |
|
Congratulations
Dharmini Manogna, MD
Hematology and Medical Oncology Fellow
on receiving a 2024 Conquer Cancer Annual Meeting Merit Award, which recognizes high-quality abstracts and research advancements within the cancer care field. Conquer Cancer is the foundation for the American Society of Clinical Oncology.
Read more about the award here.
|
|
|
Abstract Submission Period Opens | |
|
American Society of Hematology (ASH)
Annual Meeting
December 7 - 10, 2024 -
San Diego, CA
ABSTRACT SUBMISSION PERIOD: MAY 30 - AUGUST 1
For more information and key dates for ASH 2024, click HERE.
| |
NOMINATION DEADLINE MAY 31
Tulane Research, Scholarship and Artistic Achievement Awards
The Office of Research announces the extension of the Research, Scholarship, and Artistic Achievement Awards nomination process to May 31, 2024. This will be the fourth year for these awards, which are given annually to honor outstanding scholars and recognize exceptional research achievement and impact on advancing knowledge, innovation, or creativity in science, engineering, health, arts, humanities, education, and other academic fields.
Please review the award categories and find this year’s nomination process instructions at https://research.tulane.edu/achievement-awards to nominate your faculty colleagues.
For assistance with the categories or instructions, please email Gail Louis at glouis@tulane.edu.
| |
|
LA EPSCoR is now accepting applications for the following programs:
- LAMDA Seed Funding Track 1A: Single Investigator
- LAMDA Seed Funding Track 1B: Collaborative Partnership
- LAMDA Seed Funding Track 1C: Post-Doctoral Research
- LAMDA Seed Funding Track 2: Industrial Collaboration
- LAMDA Seed Funding Track 4: STEM Outreach
Deadline for proposals is Friday, June 7, 2024. Please follow this link to their online submission system -- https://laepscor.piestar-rfx.com/ -- and view the opportunities listed there. The RFPs will also be available on their website, https://rsi.laregents.edu/programs/epscor-programs/.
| |
NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
PAR-24-153
APPLICATION DUE DATE: JUNE 18, 2024
The purpose of the NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12) is to support the training of clinical scientists in community cancer prevention, screening, intervention, control, and treatment research. Special emphasis is placed on training clinical scientists whose career goal is to improve the care and outcomes of minority health populations and populations with health disparities that are underrepresented in clinical research by increasing their access to and representation as human subjects in cancer clinical trials using an equity lens.
This Notice of Funding Opportunity (NOFO) allows the appointment of Scholars proposing to serve as the lead investigator of an independent community-based clinical trial; proposing to increase the integration of cancer health disparities research questions into clinical trials; or proposing a separate ancillary study to an existing prevention, screening, intervention, control or treatment trial; or proposing to gain research experience in a community-based clinical trial led by another investigator; or proposing to serve as leader of innovative clinical trial approaches that expand engagement of minority health populations and populations with health disparities that are underrepresented as human subjects in cancer clinical trials, as part of their research and career development.
| |
|
Forge AHEAD Pilot Grant Opportunity
The Forge AHEAD Program's new pilot grant opportunity -- made available through Tulane's partnership in the UAB Center for Clinical and Translational Science -- provides a 1-year, $50,000 award for applicants interested in conducting clinical, community, and population health research into cardiometabolic diseases. Interested applicants should also include health equity and social determinants of health components in their research plans.
The next deadline for letters of intent is June 25.
This flyer provides additional information, but please contact Andy Barton at abarton1@tulane.edu or 504-988-9038 with any questions or to set up a brief call to discuss how your research might fit this request for applications.
| |
NIAID Notice of Special Interest: Inborn Errors of Immunity / Primary Immunodeficiencies (R03, R21, R01 mechanisms)
NOT-AI-24-024
This notice applies to due dates on or after June 5, 2024, and subsequent receipt dates through March 16, 2027.
The purpose of this Notice of Special Interest (NOSI) is to support research on the discovery and characterization of Inborn Errors of Immunity (IEIs), also referred to as Primary Immunodeficiencies, to understand the causes and mechanisms of disease, enable early detection and molecular diagnosis, and support the development of strategies to treat and eventually cure these disorders.
More Information
| |
NIH: New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
PAR-24-160
STANDARD DUE DATES: 6/5, 10/5, 2/5
Funds Available and Anticipated Number of Awards: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Award Budget: Application budgets are not limited but need to reflect the actual needs of the proposed project.
The brain is a highly dynamic and consequential organ that undergoes dramatic shifts in cellular composition, connectivity, and activity patterns across the lifespan. A key factor limiting our understanding of these changes, particularly over longer time periods, is the paucity of methods to study longer-term trajectories. Better approaches are needed to link nervous system structure and function, as well as genetic and environmental influences, across time periods and levels of temporal and spatial resolution. This notice of funding opportunity encourages multidisciplinary collaborations to develop novel approaches or improve existing ones for longitudinal or cross-sectional brain measures across the lifespan. The ultimate goal of this funding opportunity is to improve our understanding of how each stage in brain development, starting from prenatal origins, leads to the next one, and how the parameters that are set at each stage predict later brain health or disease.
More Information
| |
Request for Proposals
Equity in Access Research Program
The Leukemia & Lymphoma Society (LLS) has just released a Request for Proposals (RFP) for its Equity in Access Research Program, which is dedicated to funding health services research.
They are reissuing the RFP Building Evidence for Effective Interventions to Increase Therapeutic Cancer Clinical Trial Accrual: Promoting Access for Patients from Underrepresented Groups. Awards will be a maximum of $2.5 million each, over 5 years.
Specifically, they seek proposals that will implement and evaluate interventions designed to:
- Mitigate multilevel barriers to therapeutic clinical trial accrual for underrepresented groups
- Quantitatively measure the impact of these interventions on patient accrual
They are particularly interested in proposals that address systemic, institutional, and clinician-related barriers that impede clinical trial participation.
It is not necessary for applicants to have previously conducted research in blood cancer. The due date for Letters of Intent is September 12, 2024 at 2 pm CST.
For more information, visit LLS.org/EquityinAccess
| |
|
IDEAfuel, supported by Regions Foundation, is a venture accelerator that supports select startups founded by Black, Indigenous, and other People of Color (BIPOC) with non-dilutive capital, 1:1 mentorship, exclusive business resources, and more to help their startups succeed and scale.
Launched in 2021, The Idea Village piloted this program to continue its mission of uplifting and supporting BIPOC founders across the region. With the support of generous sponsors, IDEAfuel has already distributed nearly $100,000 of non-dilutive capital in the first year alone across multiple founders who participated in the program.
IDEAfuel is open to alumni of The Idea Village's early-stage accelerator, IDEAinstitute, or to founders who commit to participating in IDEAinstitute after being accepted into the program.
Interested in participating in the upcoming cohort? Learn more and access the IDEAfuel application here. Applications are reviewed on a rolling basis.
| | |
|
American Society for Radiation Oncology (ASTRO)
Annual Meeting
Sept 29 - Oct 2, 2024
Washington, DC
CALL FOR LATE-BREAKING ABSTRACTS - JUNE 26 - JULY 12
For more information on late-breaking abstract submissions for ASTRO, click HERE.
| | |
|
Tulane Cancer Center Member and Interventional Pulmonologist Ramsy Abdelghani, MD, utilizes the Ion Robotic Bronchoscope -- normally used to remove early-stage lung tumors -- to assist a dental patient who inhaled a drill component. View WWL-TV Channel 4 Health Reporter Meg Farris's story here.
| |
Recent Member Publications | |
|
Viral reprogramming of host transcription initiation. Ungerleider NA, Roberts C, O'Grady TM, Nguyen TT, Baddoo M, Wang J, Ishaq E, Concha M, Lam M, Bass J, Nguyen TD, Van Otterloo N, Wickramarachchige-Dona N, Wyczechowska D, Morales M, Ma T, Dong Y, Flemington EK. Nucleic Acids Res. 2024 May 22;52(9):5016-5032. doi: 10.1093/nar/gkae175. PMID: 38471819
Utility of hydroxychloroquine laboratory monitoring in dermatologic and rheumatologic patients. Green M, Williams L, Boh E, Kuraitis D.
Arch Dermatol Res. 2024 May 22;316(5):194. doi: 10.1007/s00403-024-02876-7. PMID: 38775951
| |
|
The Tulane Cancer Center NGS Analysis Core team assists investigators with furthering their research through comprehensive processing and analysis of data obtained from widely used high-throughput sequencing applications.
More Information
| |
Cell Analysis Core
The Cell Analysis Core Facility is designed to collaborate with investigators and contribute to all aspects of the research process, including consultation in experimental design, data analysis and storage, troubleshooting, interpretation of results, and the preparation and production of presentation graphics.
More Information
| |
Tulane Cancer Center Membership
Please click here for Tulane Cancer Center's membership guidelines and our online application form.
| |
Subscribe to Nexus
If you know someone who is interested in subsribing to Nexus, a weekly round-up of news and information for Tulane cancer researchers, please have them contact Melanie Cross at mcross@tulane.edu.
| |
Send Us Your News / Share Your Feedback | |
Please share your feedback. Is this newsletter helpful? What other information should we include? And send us your news and announcements regarding seminars, workshops, funding opportunities, new grants, recent publications or events by emailing Melanie Cross at mcross@tulane.edu.
| | | | |
